CDEK by Data4ThePeople

Sign in Sign up

← All organizations

CytomX Therapeutics

For profitWebsite ↗

Also known as: CytomX Therapeutics | CytomX Therapeutics, Inc | CytomX Therapeutics, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Aug 28, 2024

Timeline

2000s

Mar 30, 2005
Ardais Corporation— Acquired
Jun 1, 2008
CytomX Therapeutics— Founded

Drugs by trial phase (10 distinct, 9 trials)

Phase 2 (5 own, 0 via acquisition)

Phase 1 (5 own, 0 via acquisition)

Indications

Studied for

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Ardais Corporation

Recent trials (18)

NCT06462794OfficialPhase 1Aug 28, 2024
NCT06462794Lead sponsorPhase 1Aug 28, 2024
NCT06265688Lead sponsorPhase 1Apr 2, 2024
NCT06265688OfficialPhase 1Apr 2, 2024
NCT05387265OfficialEarly Phase 1Feb 22, 2022
NCT05387265Lead sponsorEarly Phase 1Feb 22, 2022
NCT04596150Study directorPhase 2Dec 15, 2020
NCT04596150Lead sponsorPhase 2Dec 15, 2020
NCT03993379Study directorPhase 2Jul 31, 2019
NCT03993379Lead sponsorPhase 2Jul 31, 2019
NCT03706274Lead sponsorPhase 1Jun 30, 2019
NCT03706274Study directorPhase 1Jun 30, 2019
NCT03543813Study directorPhase 1/Phase 2Jun 15, 2018
NCT03543813Lead sponsorPhase 1/Phase 2Jun 15, 2018
NCT03149549Lead sponsorPhase 1/Phase 2Jun 1, 2017

Details

Founded: South San Francisco, CA, US Jun 1, 2008
Last known activity: Aug 28, 2024